EcoR1 Capital
About EcoR1 Capital
EcoR1 Capital is a biotech-focused investment advisory firm.
Investment focus
Stages
Sectors
Portfolio (4 in our database)
NaurexNaurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.Acquired · $200M raisedReCode TherapeuticsReCode Therapeutics is a genetic medicines company developing targeted, disease-modifying therapies for life-limiting respiratory diseases.Series B · $162M raisedAccent TherapeuticsAccent Therapeutics is a biopharmaceutical company.Series B · $103M raisedAshvattha TherapeuticsAshvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.Series B · $98M raised